57 related articles for article (PubMed ID: 24637363)
1. Variable induction of PRDM1 and differentiation in chronic lymphocytic leukemia is associated with anergy.
Duckworth A; Glenn M; Slupsky JR; Packham G; Kalakonda N
Blood; 2014 May; 123(21):3277-85. PubMed ID: 24637363
[TBL] [Abstract][Full Text] [Related]
2. NFAT2 is a critical regulator of the anergic phenotype in chronic lymphocytic leukaemia.
Märklin M; Heitmann JS; Fuchs AR; Truckenmüller FM; Gutknecht M; Bugl S; Saur SJ; Lazarus J; Kohlhofer U; Quintanilla-Martinez L; Rammensee HG; Salih HR; Kopp HG; Haap M; Kirschniak A; Kanz L; Rao A; Wirths S; Müller MR
Nat Commun; 2017 Oct; 8(1):755. PubMed ID: 28970470
[TBL] [Abstract][Full Text] [Related]
3. The outcome of B-cell receptor signaling in chronic lymphocytic leukemia: proliferation or anergy.
Packham G; Krysov S; Allen A; Savelyeva N; Steele AJ; Forconi F; Stevenson FK
Haematologica; 2014 Jul; 99(7):1138-48. PubMed ID: 24986876
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of surface IgM of chronic lymphocytic leukemia cells induces an unfolded protein response dependent on BTK and SYK.
Krysov S; Steele AJ; Coelho V; Linley A; Sanchez Hidalgo M; Carter M; Potter KN; Kennedy B; Duncombe AS; Ashton-Key M; Forconi F; Stevenson FK; Packham G
Blood; 2014 Nov; 124(20):3101-9. PubMed ID: 25170122
[TBL] [Abstract][Full Text] [Related]
5. Anergy: the CLL cell limbo.
Caligaris-Cappio F
Blood; 2014 May; 123(21):3214-5. PubMed ID: 24855189
[No Abstract] [Full Text] [Related]
6. Developing Molecular Signatures for Chronic Lymphocytic Leukemia.
Cornet E; Debliquis A; Rimelen V; Civic N; Docquier M; Troussard X; Drénou B; Matthes T
PLoS One; 2015; 10(6):e0128990. PubMed ID: 26046539
[TBL] [Abstract][Full Text] [Related]
7. Hrd1-mediated BLIMP-1 ubiquitination promotes dendritic cell MHCII expression for CD4 T cell priming during inflammation.
Yang H; Qiu Q; Gao B; Kong S; Lin Z; Fang D
J Exp Med; 2014 Nov; 211(12):2467-79. PubMed ID: 25366967
[TBL] [Abstract][Full Text] [Related]
8. Role of Blimp-1 in programing Th effector cells into IL-10 producers.
Neumann C; Heinrich F; Neumann K; Junghans V; Mashreghi MF; Ahlers J; Janke M; Rudolph C; Mockel-Tenbrinck N; Kühl AA; Heimesaat MM; Esser C; Im SH; Radbruch A; Rutz S; Scheffold A
J Exp Med; 2014 Aug; 211(9):1807-19. PubMed ID: 25073792
[TBL] [Abstract][Full Text] [Related]
9. Cancer-Associated Fibroblasts and Squamous Epithelial Cells Constitute a Unique Microenvironment in a Mouse Model of Inflammation-Induced Colon Cancer.
Vega PN; Nilsson A; Kumar MP; Niitsu H; Simmons AJ; Ro J; Wang J; Chen Z; Joughin BA; Li W; McKinley ET; Liu Q; Roland JT; Washington MK; Coffey RJ; Lauffenburger DA; Lau KS
Front Oncol; 2022; 12():878920. PubMed ID: 35600339
[TBL] [Abstract][Full Text] [Related]
10. Biological and Clinical Insight from Analysis of the Tumor B-Cell Receptor Structure and Function in Chronic Lymphocytic Leukemia.
Forconi F; Lanham SA; Chiodin G
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158929
[TBL] [Abstract][Full Text] [Related]
11. Differential pre-malignant programs and microenvironment chart distinct paths to malignancy in human colorectal polyps.
Chen B; Scurrah CR; McKinley ET; Simmons AJ; Ramirez-Solano MA; Zhu X; Markham NO; Heiser CN; Vega PN; Rolong A; Kim H; Sheng Q; Drewes JL; Zhou Y; Southard-Smith AN; Xu Y; Ro J; Jones AL; Revetta F; Berry LD; Niitsu H; Islam M; Pelka K; Hofree M; Chen JH; Sarkizova S; Ng K; Giannakis M; Boland GM; Aguirre AJ; Anderson AC; Rozenblatt-Rosen O; Regev A; Hacohen N; Kawasaki K; Sato T; Goettel JA; Grady WM; Zheng W; Washington MK; Cai Q; Sears CL; Goldenring JR; Franklin JL; Su T; Huh WJ; Vandekar S; Roland JT; Liu Q; Coffey RJ; Shrubsole MJ; Lau KS
Cell; 2021 Dec; 184(26):6262-6280.e26. PubMed ID: 34910928
[TBL] [Abstract][Full Text] [Related]
12. miR-181d/RBP2/NF-κB p65 Feedback Regulation Promotes Chronic Myeloid Leukemia Blast Crisis.
Zhou M; Yin X; Zheng L; Fu Y; Wang Y; Cui Z; Gao Z; Wang X; Huang T; Jia J; Chen C
Front Oncol; 2021; 11():654411. PubMed ID: 33842368
[TBL] [Abstract][Full Text] [Related]
13. IRF4 modulates the response to BCR activation in chronic lymphocytic leukemia regulating IKAROS and SYK.
Maffei R; Fiorcari S; Benatti S; Atene CG; Martinelli S; Zucchini P; Potenza L; Luppi M; Marasca R
Leukemia; 2021 May; 35(5):1330-1343. PubMed ID: 33623139
[TBL] [Abstract][Full Text] [Related]
14. A pilot clinical trial of oral tetrahydrouridine/decitabine for noncytotoxic epigenetic therapy of chemoresistant lymphoid malignancies.
Hill B; Jagadeesh D; Pohlman B; Dean R; Parameswaran N; Chen J; Radivoyevitch T; Morrison A; Fada S; Dever M; Robinson S; Lindner D; Smith M; Saunthararajah Y
Semin Hematol; 2021 Jan; 58(1):35-44. PubMed ID: 33509441
[TBL] [Abstract][Full Text] [Related]
15. Differential epigenetic regulation between the alternative promoters, PRDM1α and PRDM1β, of the tumour suppressor gene PRDM1 in human multiple myeloma cells.
Romero-García R; Gómez-Jaramillo L; Mateos RM; Jiménez-Gómez G; Pedreño-Horrillo N; Foncubierta E; Rodríguez-Gutiérrez JF; Garzón S; Mora-López F; Rodríguez C; Valor LM; Campos-Caro A
Sci Rep; 2020 Sep; 10(1):15899. PubMed ID: 32985591
[TBL] [Abstract][Full Text] [Related]
16. Genetic Loss of LCK Kinase Leads to Acceleration of Chronic Lymphocytic Leukemia.
Märklin M; Fuchs AR; Tandler C; Heitmann JS; Salih HR; Kauer J; Quintanilla-Martinez L; Wirths S; Kopp HG; Müller MR
Front Immunol; 2020; 11():1995. PubMed ID: 32983140
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic Cancer Vaccines-T Cell Responses and Epigenetic Modulation.
Kartikasari AER; Prakash MD; Cox M; Wilson K; Boer JC; Cauchi JA; Plebanski M
Front Immunol; 2018; 9():3109. PubMed ID: 30740111
[TBL] [Abstract][Full Text] [Related]
18. Age-related changes in the BACH2 and PRDM1 genes in lymphocytes from healthy donors and chronic lymphocytic leukemia patients.
Chi VLD; Garaud S; De Silva P; Thibaud V; Stamatopoulos B; Berehad M; Gu-Trantien C; Krayem M; Duvillier H; Lodewyckx JN; Willard-Gallo K; Sibille C; Bron D
BMC Cancer; 2019 Jan; 19(1):81. PubMed ID: 30654767
[TBL] [Abstract][Full Text] [Related]
19. Chronic Lymphocytic Leukemia B-Cell Normal Cellular Counterpart: Clues From a Functional Perspective.
Darwiche W; Gubler B; Marolleau JP; Ghamlouch H
Front Immunol; 2018; 9():683. PubMed ID: 29670635
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
